Evidence map›Paper›PMID 40958764›Full record

ReviewJournal of chemical information and modeling2025

Integrating Machine Learning into Free Energy Perturbation Workflows.

Donald J M van Pinxteren, Willem Jespers

Abstract readReview
In one paragraph

Review in Journal of chemical information and modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Donald J M van PinxterenDepartment of Medicinal Chemistry, Photopharmacology and Imaging, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.ORCID 0009-0003-6055-8938
Willem JespersDepartment of Medicinal Chemistry, Photopharmacology and Imaging, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.ORCID 0000-0002-4951-9220

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Free energy perturbation (FEP) methods are among the most accurate tools in structure-based drug design for predicting protein-ligand binding affinities. However, their adoption remains limited due to high computational demands and complex setup procedures. This review explores how integrating machine learning (ML), especially active learning (AL) and deep learning (DL), can enhance the efficiency, accessibility, accuracy, and precision of FEP workflows. It examines three key areas where ML has been successfully applied: sampling strategies, protocol optimization, and force field development. AL algorithms can significantly reduce the number of FEP calculations needed during virtual screening by guiding the molecule selection. DL-based protein-ligand cofolding methods such as AlphaFold, NeuralPLexer, and DragonFold enable the automated generation of accurate complex structures for FEP, bypassing traditional docking and preparation steps. Additionally, ML-derived neural network potentials (NNPs), trained on quantum mechanical data, offer improved force field accuracy, although at the cost of higher computational expenses. This review emphasizes a hybrid approach combining human expertise with ML tools as the most promising strategy for accelerating and democratizing FEP-based drug discovery. Future developments in this interdisciplinary space are expected to expand the scope and impact of computer-aided drug design across pharmaceutical and materials science applications.

Indexed as

Machine LearningProteinsThermodynamicsWorkflowDrug DesignDrug DiscoveryHumansLigandsLigandsProteins

Identifiers

PMID40958764
PMCPMC12529772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.